{"id":"W1993609519","doi":"10.1016/j.ejpn.2015.02.008","title":"Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study","year":2015,"lang":"en","type":"article","venue":"European Journal of Paediatric Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"UCB Pharma; H. Lundbeck A/S; Upsher-Smith; Sunovion; Pfizer; Viropharma; GlaxoSmithKline; Eisai; Valeant Pharmaceuticals International","keywords":"Perampanel; Somnolence; Placebo; Medicine; Anesthesia; Adverse effect; Adjunctive treatment; MedDRA; Epilepsy; Post-hoc analysis; Psychology; Internal medicine; Psychiatry; Pharmacovigilance","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007190715,0.0002398281,0.002003795,0.0004092209,0.00003835733,0.0000117257,0.00009927664,0.0000363288,0.000002295541],"category_scores_gemma":[0.001668137,0.0001384882,0.0001202127,0.0002251475,0.0003322136,0.00006223289,0.0001296011,0.0006662784,0.000001095717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002745156,"about_ca_system_score_gemma":0.0001609548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001206643,"about_ca_topic_score_gemma":0.00004642985,"domain_scores_codex":[0.9931837,0.003939476,0.001752846,0.0003262358,0.0004943798,0.0003033482],"domain_scores_gemma":[0.9966734,0.001637744,0.0007037537,0.0001965483,0.0004069154,0.0003816539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6638471,0.004729671,0.3255498,0.0000265911,0.0003243134,0.003551209,0.0007445259,0.00003276724,0.000003214863,0.000002595072,0.00004729113,0.0011409],"study_design_scores_gemma":[0.6789904,0.01861967,0.3014735,0.00006163753,0.0004486798,0.00005683775,0.0001914817,0.00007559864,0.000001148362,0.000007293895,0.000007266698,0.00006644827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924625,0.003458901,0.00001515875,0.000715274,0.0001561463,0.0031613,0.000001951887,0.000005861584,0.00002286688],"genre_scores_gemma":[0.9984982,0.001139463,0.00006369563,0.0001020101,0.0001508707,0.00001315816,0.000002265941,0.00002379559,0.000006533078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02407626,"threshold_uncertainty_score":0.5647385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0678808821006577,"score_gpt":0.360664491566171,"score_spread":0.2927836094655134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}